Merck (MRK) PT Lowered to $80 at BofA Securities on Weak Report and Spinoff Concerns
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham lowered the price target on Merck (NYSE: MRK) to $80.00 (from $88.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
